BSEInsider Trading / SAST3d ago · 22 Sept 2026, 02:29 pm

Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the securities of he Company shall remained closed from October 01, 2026 till 48 hours after the Public announcement through Board of Directors in their meeting held for announcing the Unaudited Standalone and Consolidated Financial Results for the ....

Gennex Laboratories Ltd · 531739

✦ AI SummaryResults

Gennex Laboratories Ltd has announced the closure of its trading window from October 01, 2026, until 48 hours after the public announcement of its unaudited standalone and consolidated financial results for the second quarter and half-year ended on September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gennex Laboratories Ltd - 531739 - Closure of Trading Window

Attachments (1)

📄

605bbe81-3a84-4059-ba79-26a5ba1850ce.pdf

pdf

Download →
View document text
te —-s G GENNEX Ref: GLL// 202B6-2S7 /SEep - Date: September 22, 2026 To To The General Manager, The Listing Manager, Corporate Relations Department, The Ahmedabad Stock Exchange Limited BSE Limited A-2, Kamdhenu Complex, Opp. Sahajanand Phiroze Jeejeebhoy Towers, College, 120 Feet Ring Road, Panjara Pol, Dalal Street, Mumbai - 400001. Ambawadi, Ahmedabad - 380015. Maharashtra State, India. Gujarat State, India. Script Code: 531739 Script Code: The Calcutta Stock Exchange Limited, #7, Lyons Range, Murgighata, Dalhousie, Kolkata - '700001, West Bengal State, India. Scrip Code: 26178 Dear Sir/Madam, Sub: Intimation of Closure of Trading Window Ref: BSE Security ID: GENNEX, Script Code: 531739 & 890171 Notice is hereby given that in pursuance of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the securities of the Company shall remain closed from October 01, 2026 till 48 hours after the public announcement through Board of Directors in their Meeting held for announcing the Un- audited Standalone and Consolidated Financial Results for the Second Quarter and Half year ended on September 30, 2026 along with other matters for which trading window is required to be closed. The Board Meeting date to approve the Un-audited Standalone and Consolidated financial results of the Company for the Second Quarter and Half year ended on September 30, 2026 will be informed in due course. All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window. We request you to take the above information on record and acknowledge the receipt of the same. Thanking you, Yours faithfully For Gennex Laboratories Limited ic > f Dinesh Kumar Kejriwal Company Secretary & Compliance Officer M. No.-A/19293 Gennex Laboratories Limited Office: ‘Akash Ganga’ 4" Floor, Plot NO.144, Srinagar colony, Hyderabad-500073, T.S. India | Phone: +91-40-67334400 (30 Lines), Fax: +91-40-67334433 Factory: Sy.No.133, IDA Bollaram, Jinnaram Mandal, Sangareddy Dist — 502325, Telangana, India | Tel: +91-08458 279406, Telefax: +91-08454 279516 Info(@gennexlab.com, www.gennexlab.com i CIN :L24230TG1990PLC011168